Setback for Pfizer in appeal over Nigerian Trovan claims
This article was originally published in Scrip
Executive Summary
The US Justice Department's solicitor general has filed an amicus brief urging the Supreme Court to deny Pfizer's petition for review of a January 2009 federal appeals court ruling reinstating claims in actions brought by more than 80 Nigerian families who claim injuries from the company's 1996 Trovan (trovafloxacin mesylate) paediatric clinical trial.